David Montgomery

David Montgomery currently serves as Associate Director of Corporate Development, Search and Evaluation at Revolution Medicines, a position held since April 2019, with previous roles including Senior Manager and Senior Scientist I in the same division. Prior experience includes Senior Scientist at Pfizer focusing on oncology and chemical biology from July 2017 to April 2019, and a Postdoctoral Research Associate at the National Institute of General Medical Sciences from September 2014 to June 2017. Additionally, David Montgomery held a Postdoctoral Fellow position at the National Cancer Institute, where research centered on chemical biology and cancer-related enzyme activity. An early career role as a Data Analyst at the American Institutes for Research occurred in 2000. Educational qualifications include a PhD in Chemistry from Caltech and a B.S. in Chemistry from the University of California, Berkeley.